Sentinel lymph node biopsy for eyelid and conjunctival tumors: what is the evidence?

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

6 citing papers in PubMed.

1. Dramatic Response to Palliative Radiotherapy in Advanced Eyelid Squamous Cell Carcinoma: A Case Report.Journal of hospice and palliative care · 2025
   Article
2. Squamous cell carcinoma of the eyelid.Japanese journal of clinical oncology · 2024
   Article
3. Management Issues in Conjunctival Tumours: Conjunctival Melanoma and Primary Acquired Melanosis.Ophthalmology and therapy · 2019
   Review
4. White papules in lower right eyelid as a manifestation of mucoepidermoid carcinoma.JAAD case reports · 2019
   Article
5. Eye-Sparing Treatment for Diffuse Invasive Conjunctival Melanoma.Ocular oncology and pathology · 2018
   Article
6. Sentinel Node Biopsy for Conjunctival Melanoma; Single Centre Experience and Review of Current Literature.Cancer control : journal of the Moffitt Cancer Center
   Observational

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as